This page is the continuation of reference in support of Section 5e.
REFERENCES
Allred, D.C., Wu, Y., Mao, S., et al. (2008). Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res. 14(2), 370-378. (Retrieved November 6th 2014): http://clincancerres.aacrjournals.org/content/14/2/370.abstract?ijkey=bc8a60dd7a27f0d27049f08e9a718504d8736972&keytype2=tf_ipsecsha
Allred, D.C. Biological features of human premalignant breast disease and the progression to cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.
Allred, D.C. (2010). Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 41:134-8. (Retrieved November 6th 2014): https://academic.oup.com/jncimono/article/2010/41/134/890446
American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition, Edge, S.B., Byrd, D.R., Compton, C.C., et al (Eds), Springer, New York 2010.
Austin R.M., Dupree W.B. (1986). Liposarcoma of the breast: a clinocopathological study of 20 cases. Hum Pathol 17, 906-913. (Retrieved November 14th 2014): http://www.ncbi.nlm.nih.gov/pubmed/?term=Hum+Pathol++1986%3B+17%3A906-913.
Beatty SD, Atwood M, Tickman R, Reiner M. Metaplastic breast cancer: clinical significance. Am J Surg. 2006;191:657–664. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16647355
Bernstein, L. The epidemiology of breast carcinoma in situ. In: Silverstein ML, editor. Ductal Carcinoma In Situ of the Breast. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002.
Bijker, N., Meijnen, P., Peterse, J.L., et al. (2006). Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III Trial 10853—A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16801628
Bloom, H.J., Richardson, W.W. (1957). Histological grading and prognosis in breast cancer. A study of 1,409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3), 359-377. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073885/
Bradley, S.J., Weaver, D.W., Bowman, D.L. (1990). Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Am J Surg 56(7):428. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/2164336
Cayari, R., McGuire, L., Weinstein, S., Lakhani, S. (2010). Mucoepidermoid carcinoma of the breast. A case report and review of the literature. 42,81. (Retrieved November 14th 2014): https://journals.lww.com/pathologyrcpa/Fulltext/2010/42001/1
Cheson, B.D., Fisher, R.I., Barrington, S.F., et al. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol 32(27), 3059-67. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979083/
Chuba, P.J., Hamre, M.R., Yap, J., Severson, R.K., Lucas, D., Shamsa, F., Aref, A. (2005). Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 23(24):5534. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16110014
Collins, L.C., Baer, H.J., Tamimi, R.M., Connolly, J.L., Colditz, G.A., Schnitt, S.J. (2007). Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109(2), 180. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/17154175
Cotton, D.W. (1984). Measuring melanomas: the Vernier method. J Clin Pathol 37:229-230 doi:10.1136/jcp.37.2.229 (Retrieved November 14th 2014): https://jcp.bmj.com/content/37/2/229.long
Coyne, J.D., Dervan, P.A. (2002). Primary acinic cell carcinoma of the breast. Journal of Clinical Pathology 55(7), 545–547. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12101208
Darby, S.C., McGale, P., Taylor, C.W., et al. (2005). Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16054566
De Leeuw, W.J., Berx, G., Vos, C.B., Peterse, J.L., Van de Vijver, M.J., Litvinov, S., Van Roy, F., Cornelisse, C.J., Cleton-Jansen, A.M. (1997). Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183(4), 404. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/9496256
Dupont, W.D., Page, D.L. (1985). Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3), 146-151. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/3965932
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (2005). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366, 2087-2106. (Retrieved November 13th 2014): https://www.sciencedirect.com/science/article/pii/S0140673605678877
Elston, C.W., Ellis, I.O. (1991). Pathologic prognostic factors in breast cancer. I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19(5), 403–10. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/1757079
Fisher, E.R., Dignam, J., Tan-Chiu, E., Costantino, J., Fisher, B., Paik, S., Wolmark, N. (1999). Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86(3), 429. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed?term=10430251
Fisher, E.R., Land, S.R., Fisher, B., Mamounas, E., Gilarski, L., Wolmark, N. (2004). Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100(2):238. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/14716756
Fitzgibbons, P.L., Henson, D.E., Hutter, R.V.P. (1998). Benign breast changes and the risk for subsequent breast cancer – An update of the 1985 consensus statement. Arch Pathol Lab Med. 122, 1053–1055. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/9870852
Grabowski, J., Salzstein, S.L., Sadler, G.R., Blair, S.L. (2007). Malignant phyllodes tumors: a review of 752 cases. 73(10), 967-9. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/17983058
Hughes, L.L., Wang, M., Page, D.L., Gray, R., Solin, L.J., Davidson, N.E., Lowen, M.A., Ingle, J.N., Recht, A., Wood, W.C. (2009). Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27(32), 5319. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773217/
Joks, M., Mysliwiec, K., Lewandowski, K. (2011). Primary breast lymphoma – a review of the literature and report of three cases. Arch Med Sci 7(1), 27-33. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258687/
Julen, O., Dellacasa, I., Pelte, M.F., Borish, B., Bouchardy, C., Capanna, F., Vlastos, G., Dubuisson, J.B., Vlastos, A.T. (2009). Primary breast lymphomas. Rare Tumors 1(1):e14. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994446/
Kellogg, B.C., Hiro, M.E., Payne, W.G. (2014). Implant-associated anaplastic large cell lymphoma: beyond breast prostheses. Ann Plast Surg 73(4), 461-4. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/23722577
King, T.A., Muhsen, S., Patil, S., Koslow, S., Oskar, S., Park, A., Morrogh, M., Sakr, R.A., Morrow, M. (2013). Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 142(2), 445-53. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871867/
Lakhani, S., Ellis, I., Schnitt, S., et al. (2012). WHO Classification of Tumours of the Breast, 4th ed. Lyon, IARC Press. (Retrieved November 6th 2014): http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4004
Li, C.I., Anderson, B.O., Daling, J.R., Moe, R.E. (2003). Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289, 1421–1424. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12636465
Li, C.I., Uribe, D.J., Daling, J.R. (2005). Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9),1046. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361680/
Nascimento, A.F., Raut, C.P., Fletcher, C.D. (2008). Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol 32(12), 1896-904. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/18813119
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. (Retrieved November 6th 2014): http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. (1982).Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5, 649-655. (Retrieved November 14th 2014): http://www.ncbi.nlm.nih.gov/pubmed/7165009 http://www.npcrc.org/files/news/ECOG_performance_status.pdf
Orvieto, E., Maiorano, E., Bottiglieri, L., Maisonneuve, P., Rotmensz, N., Galimberti, V., Luini, A., Brenelli, F., Gatti, G., Viale, G. (2008). Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer. 2008;113(7):1511. (Retrieved November 14th 2014): http://onlinelibrary.wiley.com/doi/10.1002/cncr.23811/abstract;jsessionid=D749E671C9146F88E0664E47E09F40EB.f04t04
Page DL, Anderson TJ. Diagnostic Histopathology of the Breast, Churchill Livingstone, Edinburgh 1987.
Page, D.L., Salhany, K.E., Jensen, R.A., et al. (1996). Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78:258-266. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8674001
Page, D.L., Schuyler, P.A., Dupont, W.D., Jensen, R.A., Plummer,W.D. Jr, Simpson, J.F. (2003). Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361(9352), 125. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12531579
Pradier, C., Cornuau, M., Norca, J., Mesbah, H., Poree, P., Body, G., Classe, J-M, Leveque, J. (2011). Differences in Breast Carcinoma In Situ Between Menopausal and Premenopausal Women. Anticancer Res 31 (5), 1783-1788. (Retrieved November 13th 2014): http://ar.iiarjournals.org/search?author1=PHILIPPE+POREE&sortspec=date&submit=Submit
Rakha, E.A., El-Sayed, M.E., Lee, A.H., Elston, C.W., Grainge, M.J., Hodi, Z., Blamey, R.W., Ellis, I.O. (2008). Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 26(19), 3153-8. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/18490649
Rakha, E.A., Ellis, I.O. (2010). Lobular breast carcinoma and its variants. Semin Diagn Pathol 27(1), 49-61. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/20306830
Rakha, E.A., van Deurzen, C.H., Paish, E.C., Macmillan, R.D., Ellis, I.O., Lee, A.H. (2013). Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade? Mod Pathol 26(4), 496-501. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/23238630
Rosen, P.P., Oberman, H. Tumors of the Mammary Gland, Armed Forces Institute of Pathology, Washington, DC 1993.
Sapino, A., Righi, L., Cassoni, P., Papotti, M., Pietribiasi, F., Bussolati, G. (2000). Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol. 17, 127–37. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/10839613
Schairer, C., Mink, P.J., Carroll, L., et al. (2004). Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96, 1311-1321. (Retrieved November 6th 2014): https://academic.oup.com/jnci/article/96/17/1311/2520929
Schonberg, M.A., Marcantonio, E.R., Ngo, L., Li, D., Silliman, R.A., McCarthy, E.P. (2011). Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol 29(12), 1570. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/21402602
Schwartz, T., Cyr, A., Margenthaler, J. (2014). Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res S0022-4804. (Retrieved November 6 2014): https://www.ncbi.nlm.nih.gov/pubmed/25277350
Silverstein, M.J., Waisman, J.R., Gamagami, P. et al. (1990). Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer 66, 102. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/2162238
Silver, S.A., Tavassoli, F.A. (1998). Primary osteogeneic sarcoma of the breast. A clinicopathologic analysis of 50 cases. Am J Surg Pathol 22, 925-933. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/9706972
Silverstein, M.J., Lagios, M.D., Craig, P.H., Waisman, J.R., Lewinsky, B.S., Colburn, W.J., Poller, D.N. (1996). A prognostic index for ductal carcinoma in situ of the breast. Cancer 77(11), 2267. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8635094
Simpson, J.L., Page, D.L. (1996). The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer. Semin Oncol. 23(4), 428-35. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8757269
Simpson, P.T., Gale, T., Reis-Filho, J.S. et al. (2005). Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29(6), 734-46. (Retrieved November 13th 2014): http://www.ncbi.nlm.nih.gov/pubmed/15897740
Sinn, H-P., Kreipe, H. (2013). A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care (Basel) 8(2), 149–154. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683948/
Solin, L.J., Fourquet, A., Vicini, F.A. et al. (2005). Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103(6), 1137. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15674853
Staley, H., McCallum, I., Bruce, J. (2012). Postoperative tamoxifen for ductal carcinoma in situ. Cochrane Database Syst Rev 10, CD007847. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/23076938
Sullivan, T., Raad, R.A., Goldberg, S., Assaad, S.I., Gadd, M., Smith, B.L., Powell, S.N., Taghian, A.G. (2005). Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 93(3),199. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16142444
Surveillance Epidemiology and End Results, National Cancer Institute (2005b). Characteristics of the SEER population compared with the total United States population. (Retrieved November 13th 2014): https://seer.cancer.gov/registries/characteristics.html
Tallent, A. (2013). ASCO and the CAP Release Updated Guideline on HER2 Testing in Breast Cancer. Press Release, October 7, 2013. (Retrieved November 14th 2014): https://www.asco.org/advocacy-policy/asco-in-action/twenty-oncology-practices-achieve-qopi-certification-Q2-2019
Tavassoli, F.A., Devilee, P. (eds): Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, IARC Press, 2003.
Thurman, S.A., Schnitt, S.J., Connolly, J.L., Gelman, R., Silver, B., Harris, J.R., Recht, A. (2004). Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 59(1), 152. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15093911
Vasudev, P., Onuma, K. (2011). Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med 135(12):1606-10. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/22129193
Vieira, C.C., Mercado, C.L., Cangiarella, J.F., Moy, L., Toth, H.K., Guth, A.A. (2010). Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol 73(1), 102. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/19026501
Wolff, A.C., Hammond, E., Hicks, D.G. et al. (2013). Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol 31(31), 3997-4013. (Retrieved November 12th 2014): http://www.asco.org/quality-guidelines/recommendations-human-epidermal-growth-factor-receptor-2-testing-breast-cancer
